Macrophage-stimulating protein (MSP) exerts proliferative and antiapoptotic effects, suggesting that it may play a role in tubular regeneration after acute kidney injury. In this study, elevated plasma levels of MSP were found both in critically ill patients with acute renal failure and in recipients of renal allografts during the first week after transplantation. In addition, MSP and its receptor, RON, were markedly upregulated in the regenerative phase after glycerol-induced tubular injury in mice. In vitro, MSP stimulated tubular epithelial cell proliferation and conferred resistance to cisplatin-induced apoptosis by inhibiting caspase activation and modulating Fas, mitochondrial proteins, Akt, and extracellular signalregulated kinase. MSP also enhanced migration, scattering, branching morphogenesis, tubulogenesis, and mesenchymal de-differentiation of surviving tubular cells. In addition, MSP induced an embryonic phenotype characterized by Pax-2 expression. In conclusion, MSP is upregulated during the regeneration of injured tubular cells, and it exerts multiple biologic effects that may aid recovery from acute kidney injury.
Tubular injury is a hallmark of renal function impairment in the course of acute kidney injury (AKI) of different origin. [1] [2] [3] AKI is characterized by a high incidence in critically ill patients who are admitted to the intensive care unit (ICU) and by an unchanged rate of mortality despite the improvements in the therapeutic support. 4 In the presence of injurious stimuli, tubular cells present several alterations of functional integrity and finally die by necrosis and in particular by apoptosis. [5] [6] [7] The recovery is characterized by the de-differentiation of surviving tubular cells and their migration and proliferation with restoration of tissue integrity. 8 All of these processes are orchestrated by different growth factors, such as vascular endothelial growth factor, EGF, IGF-I, and hepatocyte growth factor (HGF). 7,9 -15 Macrophage-stimulating protein (MSP) be-longs to plasminogen-related growth factors. 16 In adults, the liver is the major source of MSP that circulates in the blood as a precursor (pro-MSP) cleaved into the active form by macrophage membrane proteases and by enzymes of the coagulation cascade. 17, 18 The receptor for MSP is the proto-oncogene RON, a tyrosine kinase belonging to the growth factor receptor family that also includes MET, the HGF receptor. 19 RON plays a key role in blood cell development and in several phases of the immune response, including antigen presentation and macrophage activation. 20 -22 The MSP/RON pathway is involved in the development of bones and epithelial and neuroendocrine tissues. 23 In the kidney, RON has been observed in tubular epithelia during the development of the mouse metanephric kidney, 23 but the function of the MSP/RON pathway in adult human renal tissues remains unclear. It was demonstrated that tubular and mesangial cells express RON and that the MSP/ RON pathway may have a role in renal physiology and inflammatory glomerular disorders. 24 The aim of this study was to investigate the involvement of the MSP/RON pathway in tubular regeneration after acute injury.
RESULTS

MSP Plasma Levels Increased in Patients with AKI
We studied 25 critically ill patients with acute renal failure (ARF) included in the Failure group of ADQI-RIFLE (Acute Dialysis Quality Initiative-Risk, Injury, Failure, Loss of Kidney Function, End Stage Kidney Disease) criteria, 25 and we collected plasma for MSP determination in an early phase (days 1 through 3; n ϭ 10) and in a late phase (days 7 through 14; n ϭ 25) of ARF. Patients showed an average SOFA (Sequential Organ Failure Assessment) score and an estimation of mortality risk not significantly different from those observed in the whole ICU population with ARF treated during 1 yr (n ϭ 118; Table 1 ). In comparison with healthy volunteers (n ϭ 10), ICU patients with ARF presented significantly higher MSP plasma levels ( Figure 1A ). The levels of MSP were significantly higher in the late than in the early phase of ARF. In addition, in patients with ARF, the MSP levels were significantly higher than in the ICU population with preserved renal function (n ϭ 25; Figure 1A ). No significant differences in the APACHE (Acute Physiology and Chronic Health Evaluation) II score was observed in the groups ICU early ARF (22.2 Ϯ 1.1), ICU late ARF (21.8 Ϯ 1.9), and ICU without ARF (21.0 Ϯ 0.7). MSP levels were normal in patients with chronic renal failure (CRF; n ϭ 10); however, when the same patients with CRF underwent renal transplantation, a significant increase of MSP was observed in the first week after the procedure (kidney Tx week 1) to decrease when a stable graft function was reached (kidney Tx week 8; Figure 1A ).
Enhanced Production of MSP by Human Tubular Epithelial Cells Exposed to Detrimental Conditions
Exposure of immortalized tubular epithelial cells (TEC) to subcytotoxic dosages of cisplatin (0.01 to 1.00 g/ml) for 24 h resulted in a significant increase of MSP in the supernatants with respect to vehicle alone ( Figure 1B ). No apoptosis of TEC was observed with these dosages of cisplatin (data not shown).
In contrast, a cytotoxic dosage of cisplatin (5 g/ml) induced an early MSP production at 6 h followed by a decrease at 12 and 24 h ( Figure 1C ) in concomitance with the appearance of apoptosis. Similarly, serum deprivation increased MSP production by TEC at 6 h followed by a significant decrease at 12 and 24 h ( Figure 1C ). These data were confirmed by immunofluorescence analysis ( Figure 1 , D through F) showing an enhanced intracytoplasmic expression of MSP 6 h after serum deprivation ( Figure 1E ) or treatment with 5 g/ml cisplatin ( Figure  1F ). Similar results were obtained with primary TEC (data not shown).
TEC Expressed RON Receptor
By reverse transcription-PCR (RT-PCR), we found the expression of RON mRNA in both primary and immortalized TEC ( Figure 2G ). The Western blot analysis showed the knockdown of MET (HGF receptor) and RON proteins by specific small interference RNA (siRNA) in immortalized TEC ( Figure 2H ). These results were confirmed by RT-PCR analysis (data not shown).
MSP and RON Were Upregulated in Tubules after
Glycerol-Induced AKI in C57Bl/6 Mice Control C57Bl/6 mice that were administered an injection of vehicle alone showed normal histology ( Figure 3A ) and levels of serum creatinine (sCr) and urea (sU; sCr 0.22 Ϯ 0.09 mg/dl; sU 31.66 Ϯ 4.25 mg/dl). In contrast, in mice that were administered an injection of glycerol, we observed after 3 d marked signs of tubular injury ( Figure 3A ) characterized by hyaline cast formation, widespread necrosis, cytoplasmic vacuolization, mitochondrial alterations, and loss of the brush border. 26 BASIC RESEARCH www.jasn.org At day 3, the maximal rise of sCr and sU was found (sCr 1.53 Ϯ 1.01 mg/dl; sU 367.68 Ϯ 56.32 mg/dl). After 10 d, mouse kidneys showed features of spontaneous tubular regeneration ( Figure 3A) , confirmed by the decline of biochemical data (sCr 0.33 Ϯ 0.11 mg/dl; sU 78 Ϯ 6 mg/dl) to complete recovery of normal morphology 21 d after injury ( Figure 3A) . By immunohistochemistry, control C57Bl/6 mice showed a weak tubular staining for both RON and MSP ( Figure 3A ). RON and MSP staining was almost completely abrogated 3 d after glycerol injection ( Figure 3A) . By contrast, at day 10, during the phase of regeneration, tubules showed a marked upregulation of RON and MSP staining to decrease to normal levels after 21 d ( Figure 3A ). These data were confirmed by semiquantitative analysis of average fluorescence intensity ( Figure 3B ) and Western blot analysis of kidney lysates ( Figure 3C ) for each time point considered. In mice, the plasma levels of MSP before injury were 1.82 Ϯ 0.22 ng/ml. MSP plasma levels decreased in concomitance with the peak of tubular injury (day 3 0.54 Ϯ 0.16 ng/ml) and increased in the regenerative phase (day 10 7.5 Ϯ 1.23 ng/ml) to decline thereafter (day 21 3.75 Ϯ 0.94 ng/ml). By confocal microscopy, MSP co-localized with megalin, suggesting its expression by proximal TEC (Figure 4) . No co-localization of MSP was observed with Tamm-Horsfall protein and aquaporin-2, suggesting its absence or its minimal expression in the thick ascending limb of Henle's loop and in collecting ducts (Figure 4 ).
MSP Exerted a Proliferative and Antiapoptotic Effect on TEC
TEC were incubated with increasing dosages of MSP (0.1 to 100.0 ng/ml) or with HGF (10 ng/ml) as positive control. In preliminary experiments based on XTT assay, we found that MSP increased the cell number in primary and immortalized TEC culture ( Figure 5A ). The following experiments were performed with immortalized TEC. The 5-bromo-2Ј-deoxy-uridine (BrdU) incorporation into DNA after MSP stimulation indicated a significant increase of proliferation detectable at the dosage of 1 ng/ml, with a peak at 50 ng/ml ( Figure 5B ). The co-incubation with the phosphatidylinositol-3-kinase inhibitor wortmannin (0.1 M) or with PD98059 (20 M), a specific Figure 1 . Evaluation of MSP plasma levels in patients with ARF and of MSP release from TEC cultured in detrimental conditions. (A) ELISA analysis of MSP plasma levels (ng/ml) in healthy volunteers (Healthy; n ϭ 10), in critically ill patients with normal renal function (ICU; n ϭ 10), in the early phase (ICU early ARF; n ϭ 10) or in the late phase (ICU late ARF; n ϭ 25) of ARF, and in patients with CRF (CRF Pre Tx; n ϭ 10) before or in the first or the eighth week after kidney transplantation. # P Ͻ 0.05 12 or 24 h with 5 g/ml cisplatin versus 6 h with 5 g/ml cisplatin. (D through F) Representative immunofluorescence micrographs of MSP staining in TEC cultured for 6 h in basal conditions (D), in serum deprivation (E), or with 5 g/ml cisplatin (F). Nuclei were counterstained by 1 g/ml propidium iodide. Five experiments were performed with similar results. Magnification, ϫ100.
inhibitor of Mek that activates extracellular signal-regulated kinase (ERK), 27 resulted in a significant decrease of MSP-induced proliferation ( Figure 5B ). MSP-induced proliferation was not inhibited by the co-incubation with a blocking anti-MET antibody or in TEC transfected with MET siRNA ( Figure  5B ). In contrast, MSP-induced proliferation was blocked in TEC transfected with RON siRNA ( Figure 5B ). MSP (10 ng/ ml) increased TEC viability also in the presence of 5 g/ml cisplatin (data not shown). This protective effect was due to the inhibition of cisplatin-induced apoptosis. Indeed, as shown by terminal deoxynucleotidyltransferase-mediated dUTP nickend labeling (TUNEL) assay ( Figure 5C ), MSP significantly reduced apoptosis of TEC cultured in condition of serum deprivation or with 5 g/ml cisplatin. The antiapoptotic effect of MSP was partially inhibited by wortmannin or PD98059 (Figure 5C ). MSP-induced resistance to apoptosis was not affected by co-incubation with a blocking anti-MET antibody or in TEC transfected with MET siRNA ( Figure 5C ). In contrast, MSP protection from cisplatin-induced apoptosis was blocked in TEC transfected with RON siRNA ( Figure 5C ). The antiapoptotic activity of MSP was further confirmed by the disappearance of chromatin fragmentation ( Figure 5C , inset) and by propidium iodide staining ( Figure 5 , D and E). The effect of MSP was not restricted to cisplatin-induced cell death, because a significant decrease of apoptosis was also observed in TEC incubated with cyclosporine (1 g/ml), FK506 (1 g/ml), LPS (50 ng/ml), or TNF-␣ (30 ng/ml; data not shown).
MSP Reduced Caspase Activity, Fas Upregulation, and Fas-Enhanced Apoptosis and Modulated Akt/ERK Phosphorylation and Bcl-xL Expression in CisplatinTreated TEC MSP (10 ng/ml) induced a significant reduction of caspase-3, -8, and -9 activity in cisplatin-treated TEC ( Figure 5F ). Agonistic anti-Fas IgM antibody (100 ng/ml) or supernatants from COS cells transfected with human Fas ligand (Fas-L) cDNA 28 induced a significant increase of apoptosis in cisplatin-treated TEC but not in cells maintained in basal culture conditions ( Figure 5G ). The apoptotic rate of cisplatin-treated TEC was not affected by supernatants derived from mock-transfected COS ( Figure 5G ). MSP significantly inhibited the enhancement of apoptosis induced by anti-Fas IgM or COS Fas-L supernatants. These data suggest that MSP inhibited the sensitization of cisplatin-treated TEC to Fas-mediated apoptosis. Moreover, FACS ( Figure 6 , A through C) and immunofluorescence ( Figure 6 , D through F) showed that MSP significantly reduced the expression of Fas on cisplatin-treated TEC. As shown by Western blot and related densitometric analysis (Figure 6G) , MSP prevented the decrease of Bcl-xL expression as well as of Akt and ERK phosphorylation induced by serum deprivation or cisplatin.
MSP Induced Vimentin Upregulation and Pax-2 Expression in Surviving TEC
We investigated the effect of MSP on the expression of the mesenchymal marker vimentin and of the embryonic protein Pax-2. TEC basally expressed vimentin that was almost completely lost after 24 h of serum withdrawal ( Figure 7A ) or in the presence of 5 g/ml cisplatin ( Figure 7C ). By contrast, vimentin was re-expressed in serum-deprived ( Figure 7B ) and cisplatin-treated ( Figure 7D ) TEC after stimulation with 10 ng/ml MSP. TEC did not express in basal conditions, as well as after serum deprivation or cisplatin treatment, the Pax-2 embryonic antigen. When treated with MSP, TEC expressed Pax-2 as detected by nuclear immunostaining (Figure 7 , E through H) and Western blot analysis ( Figure 7I ). Compared with vehicle alone (Figure 9 ), 10 ng/ml MSP induced the re-distribution of actin cytoskeleton fibers and increased TEC migration that peaked at 2 h and remained significantly higher throughout all of the observation period ( Figure  10A ). MSP-induced TEC migration was dosage dependent with a significant increase found at dosages Ն1 ng/ml and peaking at 50 ng/ml ( Figure 10B ). The addition of wortmannin Figure 10C ). Blocking anti-MET antibody or MET siRNA transfection did not prevent MSP-induced migration ( Figure 10C ). In contrast, migration was abolished in TEC transfected with RON siRNA ( Figure 10C ). Moreover, MSP and HGF but not EGF induced a significant increase of scattered migration on extracellular matrices ( Figure 10D ).
MSP Induced Scattering and Branching Morphogenesis of TEC Cultured on MatrigelCoated Plates
TEC cultured for 24 h without FCS on Matrigel-coated plates formed round cell aggregates ( Figure 11A ). Addition of 10 ng/ml MSP resulted in scattering and branching morphogenesis of TEC ( Figure 11B ).
MSP Induced Tubulogenesis In Vivo
We injected subcutaneously into Matrigel plugs in SCID mice TEC transduced by a lentiviral vector expressing GFP. These cells (TEC-GFP) spontaneously formed tubular-like structures ( Figure 11C ) that were significantly increased in the presence of 10 ng/ml MSP (Figure 11, D and G) . By contrast, cisplatin completely altered TEC-GFP morphogenesis, inducing apoptosis and loss of GFP expression (Figure 11 , E, G, and H). Addition of MSP on cisplatin-treated TEC-GFP partially restored normal morphogenesis ( Figure 11F) , showing tubular-like structures with a pseudolumen and a preserved cell polarity ( Figure 11F, inset) . In addition, MSP significantly decreased the number of apoptotic cells per field ( Figure 11H ) and preserved the immunostaining for RON, megalin, and ZO-1 ( Figure  12 ), suggesting a role for this growth factor in maintaining cellular functional integrity and a correct tubular remodeling required for in vivo tubulogenesis.
DISCUSSION
In this study, we provided evidence for the involvement of the MSP/RON pathway in the regeneration of tubular cells after AKI. MSP is known to induce proliferation, resistance to apoptosis, and migration of several cell types. 20, 29 Our findings indicate that, in response to detrimental factors, TEC secrete MSP that in turn protects cells from injury. We also found that MSP plasma levels were significantly higher in ICU patients with ARF than in healthy volunteers or in ICU patients with normal renal function. When compared with normal individuals, plasma levels of MSP were elevated also in ICU patients with normal renal function. MSP production is known to take place mainly in the liver 16 ; therefore, the hepatic involvement occurring in ICU patients may concur to the elevation of plasma MSP levels. However, in patients with comparable systemic involvement, the significantly high plasma levels of MSP were observed in the presence of renal injury. The levels of MSP were higher in ICU patients in the late than in the early phase of ARF, suggesting MSP production when renal regeneration occurred. In addition, MSP was normal in patients with CRF but significantly increased in the same patients in the first week after renal transplantation in coincidence with the recovery from ischemia-reperfusion injury. The plasma levels of MSP normalized when a stable graft function was reached. These findings were further confirmed by the experimental murine model of glycerol-induced AKI, in which enhanced MSP plasma levels and tubular expression of MSP and RON were observed during the phase of spontaneous tissue repair. The experiments based on MET and RON siRNA knockdown and on antibodymediated MET inhibition indicated that MSP-triggered signals were mediated by RON and not by a cross-talk with MET. 30 Furthermore, the upregulation and release of MSP were detected in vitro in TEC subjected to subcytotoxic dosages of cisplatin, suggesting the possible involvement of an autocrine loop of the MSP/ RON pathway in the processes of tubular repair.
In the presence of injurious factors, TEC are subjected to loss of polarity with cytoskeleton alterations and mislocalization of proteins located at the apical or at the basolateral membrane and to necrosis and apoptosis. 5, [31] [32] [33] The fate of TEC in the direction of death or of a full recovery is determined by the balance between the severity and the persistence of the insult and the presence of factors able to favor tissue regeneration. 34, 35 We found that MSP stimulated proliferation of TEC and significantly inhibited cisplatin-induced apoptosis. TEC proliferation was associated with the expression of a cellular de-differentiated phenotype because MSP induced the upregulation of the mesenchymal marker vimentin 36, 37 and the reexpression of the renal embryonic gene product Pax-2. 38, 39 It was previously reported that cisplatin-induced TEC apoptosis is related to an altered expression of the Bcl-2 mitochondrial family proteins and Fas. 40, 41 We found that the antiapoptotic effect of MSP was associated with the decrease of caspase activities, the downregulation of Fas, and the reduction of sensitization to Fas-mediated apoptosis. MSP also induced the overexpression of the antiapoptotic mitochondrial protein Bcl-xL in cisplatin-treated TEC. The inhibitory effect of the anticancer drug wortmannin on MSP-induced proliferation, cell migration, and apoptosis suggests the involvement of the PI3K signaling cascade and pathways. 42 Blockade of the Mek-dependent pathway of ERK activation with PD98059 significantly reduced the biologic effects of MSP on TEC, suggesting the involvement of this pathway in MSP/RON signal transduction as previously shown for tubulogenesis induced by MET receptor activation. 27, [43] [44] [45] Apart from the inhibition of apoptosis, MSP preserved the expression of several molecules involved in physiologic tubular functions. Indeed, in cisplatin-treated TEC, MSP maintained the ability to internalize albumin and the expression of the endocytic receptor megalin that is essential for protein reabsorption. 46, 47 MSP also preserved the normal transepithelial resistance and the expression of the tight junction protein ZO-1 in cisplatin-treated TEC. These results suggest that MSP contributed to maintenance of cell polarity and selective permeability. 48 -50 After AKI, a great percentage of TEC are subjected to massive destruction, leading to the detachment of cells from basement membrane and to the back-leakage of fluid to the inter- ng/ml HGF; lane 4, FCS-plus 10 ng/ml MSP; lane 5, 5 g/ml cisplatin; lane 6, 10 g/ml cisplatin; lane 7, 5 g/ml cisplatin plus 10 ng/ml HGF; lane 8, 5 g/ml cisplatin plus 10 ng/ml MSP). ␤-Actin was used as control for protein loading. Three experiments were performed with similar results. Magnification, ϫ100.
BASIC RESEARCH www.jasn.org stitium. In this setting, surviving TEC migrate for covering the areas of denudated basement membrane. 31 We found that MSP was able to favor adhesion of TEC to matrices, migration, and in vivo tubulogenesis, suggesting a potential role of this growth factor in the correct tubular remodeling. 51 In conclusion, we provided evidence for the involvement of the MSP/RON pathway in biologic events critical for tubular repair.
CONCISE METHODS
Patients
We enrolled in the study 25 critically ill patients who had been admitted to ICU. The inclusion criterion was the presence of ARF with the need for renal replacement therapy. Selected patients were included in the "failure" group in relation to their sCr levels or urinary output in accordance to the ADQI-RIFLE criteria. 25 The severity of illness was assessed by APACHE (Acute Physiology and Chronic Health Evaluation) II and by SOFA (Sequential Organ Failure Assessment) score at the moment of ARF onset. The estimation of mortality risk in the group was performed by the Acute Tubular Necrosis-Individual Severity Score (ATN-ISS) system developed by Liano et al. 52 Patients with CRF, chronic liver failure, hepatorenal syndrome, congestive heart failure, neoplastic diseases, collagenopathies, glomerulopathies, and diabetes were excluded from the study. Plasma samples were drawn in the early phase (days 1 through 3; n ϭ 10) and in the late phase (days 7 through 14; n ϭ 25) of ARF. MSP plasma levels were also studied in 25 critically ill patients with normal renal function (exclusion from ADQI-RIFLE criteria), 10 patients with chronic ure- Representative FACS analysis of megalin expression (F through H) and FITC-albumin internalization (I through K) by TEC exposed to various stimuli. In normal culture conditions, TEC showed the presence of megalin on their surface (F) and the ability to internalize FITC-albumin (I). Incubation with 5 g/ml cisplatin significantly reduced megalin expression (G) and albumin uptake (J). In contrast, the addition of 10 ng/ml MSP to cisplatin-treated TEC restored both megalin expression (H) and albumin internalization (K). Kolomogorov Smirnov statistical analysis was performed in three different experiments. Similar results were obtained with HGF (data not shown), suggesting that the effects on TER, adhesion to extracellular matrices, tight junction protein/megalin expression, and internalization of FITC-labeled albumin were not specific for MSP. Magnification, ϫ100. mia before and 1 or 8 wk after kidney transplantation, and 10 healthy volunteers.
Kidney transplant recipients were treated with the standard induction immunodepressive protocol adopted in our center: Basiliximab (20 mg) at days 0 and 4 after transplantation, tacrolimus (0.2 mg/kg body wt per d), and steroids. In selected cases at high risk for rejection, mycophenolate mofetil (1 g/d) was added to standard therapy. Tacrolimus plasma levels were maintained in the range of 17 to 20 ng/ml (weeks 1 through 4) or 12 to 15 ng/ml (weeks 5 through 12).
MSP Determination
MSP plasma levels were determined by ELISA that detected both pro-MSP and the active dimeric form (R&D Systems, Minneapolis, MN; and Ray Biotech Inc., Norcross, GA). MSP was determined in supernatants of TEC cultured in various experimental conditions. Results were calculated after the generation of a standard curve with appropriate controls and given as averages Ϯ 1 SD.
Murine AKI Model
Animal care and treatment were conducted in conformity with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Acute toxic tubular injury in C57Bl/6 mice was induced by intramuscular injection of 7.5 ml/kg body wt 50% glycerol solution (Sigma, St. Louis, MO), as described previously. 26 Renal function was assessed by determination of sCr and sU levels using an automated chemistry analyzer (Beckman Instruments, Fullerton, CA). Mice were killed after 3, 6, 10, and 21 d from AKI induction. Six mice for each experimental group were examined. As controls, six mice were administered an injection of vehicle alone. Kidneys were formalin fixed and paraffin embedded for histology and immunohistochemistry. Immunostaining for MSP and RON was examined semiquantitatively in 10 nonsequential sections by measurement of fluorescence intensity by digital image analysis (Casti Imaging, Venezia, Italy) using a low-light video camera (Leica DC100, Wetzlar, Germany). Results are given as relative fluorescence intensity with respect to fluorescence spontaneously originated by tissue background. Co-localization of MSP with markers of proximal tubules, thick ascending limb of Henle's loop, and collecting ducts (respectively anti-megalin, TammHorsfall protein, and aquaporin-2 antibodies from Santa Cruz Biotechnology, Santa Cruz, CA) was performed by confocal microscopy (LSM5 PASCAL; Zeiss, Jena, Germany). The modulation of MSP and RON expression was confirmed by Western blot analysis of tubular cell lysates after separation from glomeruli.
Human Tubular Cell Isolation and Culture
Primary cultures of human TEC (pTEC) were obtained from kidneys removed by surgical procedures from patients affected by renal carcinomas by a technique previously described. 28 An immortalized cell line (iTEC) generated by infection with a hybrid Adeno5/SV40 virus and previously characterized 28 was used to confirm and to extend the experiments carried out with pTEC. Both cellular types were grown with RPMI 1640 (Life Technologies, Grand Island, NY) containing 10% FCS (Hyclone, Logan, UT) and 2 mM glutamine (Life Technologies). The purity of TEC cultures was assessed on the basis of cell characterization, according to published criteria. 28 TEC showed negative staining for von Willebrand factor, minimal staining for desmin and vimentin, and marked staining with antibodies directed to cytokeratins and actin. TEC were also positive for markers of fully differentiated proximal TEC such as alkaline phosphatase, aminopeptidase A, and megalin. In addition, TEC showed an enhanced cAMP production after stimulation with 100 nM parathyroid hormone. 28 
Detection of RON Receptor on TEC
Gene Expression. For the detection of RON expression by RT-PCR, total RNA was extracted from TEC by the guanidinium thyocyanate phenol-chloroform method and precipitated with isopropanol. One microgram of RNA was treated with 6 U of RNase-free DNase for 1 h at 37°C and then for 5 min at 94°C; cDNA was obtained by using random hexamer primers (Perkin-Elmer, Norwalk, CT). RT was carried out at 42°C for 60 min; in addition to 1 g of RNA, the reaction mixture (20 l) contained 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl 2 , 1.0 mM dNTP, 20 U of ribonuclease inhibitor and 50 U of Moloney murine leukemia virus reverse transcriptase (Perkin-Elmer). Obtained cDNA was subjected to 35 cycles of amplification by Figure 9 . MSP induced TEC migration and redistribution of cytoskeleton fibers. TEC stimulated for 12 h with vehicle alone or 10 ng/ml EGF (negative control) did not show the ability to migrate into a wound generated in a monolayer to create a cellular mechanical stress. In contrast, in the presence of 10 ng/ml MSP or HGF (positive control), TEC showed a marked enhancement of migration. Micrographs show the start (0) and the end (12 h) points of a representative migratory experiment recorded by time-lapse microscopy. Five experiments were performed with similar results. In accordance with migration data, incubation with 10 ng/ml MSP and HGF but not EGF or vehicle alone induced the redistribution of actin cytoskeleton that lost the typical stress fiber staining. Magnifications: ϫ100 for 0 and 12 h; ϫ200 for actin.
BASIC RESEARCH www.jasn.org the PCR in an automated DNA thermal cycler (Perkin-Elmer) by using RON mRNA-specific primer pairs: Forward 5Ј-GT-CAAGGATGTGCTGATTCCC-3Ј and reverse 5Ј-TCTGTG-GAGTGAGGTACCTAATG-3Ј. Glyceraldehyde-3-phosphate dehydrogenase was used as experimental control. PCR products were subjected to 1% agarose gel electrophoresis and analyzed under ultraviolet (UV) light.
Protein Expression.
The basal expression of RON on TEC was evaluated by Western blot, FACS, and immunofluorescence studies by using a rabbit polyclonal anti-human RON antibody (Santa Cruz Biotechnology) and appropriate horseradish peroxidase-or FITC-conjugated secondary antibodies. MSP-induced RON phosphorylation was evaluated by Western blot using a rabbit polyclonal anti-human P-RON antibody (Santa Cruz Biotechnology).
Viability and Proliferation Assays
TEC were cultured on 24-well plates (Falcon Labware, Oxnard, CA) at a concentration of 5 ϫ 10 4 cells/well and incubated with appropriate agonists and 10 M BrdU (Roche Diagnostics, Mannheim, Germany) or 250 g/ml XTT (Sigma, St. Louis, MO) in a medium lacking phenol red. The absorption values, respectively, at 405 nm (BrdU) or at 450 nm (XTT) were measured in an automated spectrophotometer at different time points. In selected experiments, the PI3K inhibitor wortmannin (0.1 M), PD98059 (20 M), a specific inhibitor of Mek that activates ERK, or a blocking anti-MET antibody (R&D Systems) was used. All experiments were performed in triplicate.
Detection of Apoptosis
TUNEL Assay. TEC were subjected to TUNEL assay (ApopTag; Oncor, Gaithersburg, MD) in accordance with the manufacturer's instructions. In selected experiments, TUNEL assay was used to evaluate the role of Fas signaling pathway after incubation of TEC with 100 ng/ml agonist anti-Fas IgM antibody (Upstate Biotechnology, Lake Placid, NY), supernatant coming from COS cells producing soluble Fas-L (4 d after transient transfection), or from mock-transfected COS cells as described previously. 28 In selected experiments, the PI3K inhibitor wortmannin (0.1 M), PD98059 (20 M), a specific inhibitor of Mek that activates ERK, or a blocking anti-MET antibody (R&D Systems) was used.
Propidium Iodide Nuclear Staining. Propidium iodide nuclear staining was used to identify DNA fragmentation. TEC were cytospun; fixed with 1% paraformaldehyde; and stained by a solution containing 50 g/ml propidium iodide, 0.1% sodium citrate (Sigma), 0.1% Triton-X-100 (Sigma), and 20 g/ml DNase-free RNase (Sigma) diluted in sterile water. All samples were examined by UV light microscopy. 
DNA Laddering Analysis.
Quick apoptotic DNA Ladder kit (BioVision, Mountain View, CA) was used to detect chromatin fragmentation in apoptotic cells in accordance with the manufacturer's instructions.
Caspase-3, -8, and -9 Activities
The activities of caspase-3, -8, and-9 were assessed by ELISA (Chemicon, Temecula, CA) on the basis of the spectrophotometric detection of the cromophore p-nitroanilide (pNA) after cleavage from the labeled substrate DEVD-pNA, which is recognized by caspases. TEC lysates were diluted with an appropriate reaction buffer, and DEVDpNA was added at a final concentration of 50 M. Samples were then analyzed in an automated ELISA reader at a wavelength of 405 nm. Each experiment was performed in triplicate.
Immunofluorescence Studies
After appropriate stimuli, cultured TEC were fixed in ethanol/acetic acid 2:1 and stained with antibodies directed to human Fas (Upstate Biotechnology), vimentin (Sigma), pan-cytokeratins (Sigma), Pax-2 (Covance, Princeton, NJ), E-cadherin (Dako, Glostrup, Denmark), albumin (R&D Systems), ZO-1, MSP, megalin, alkaline phosphatase, or aminopeptidase A (all from Santa Cruz Biotechnology). After incubation with primary antibodies, samples were washed with 1ϫ PBS and incubated with appropriated Alexa Fluor-conjugated secondary antibodies (Molecular Probes, Carlsbad, CA) for 30 min, RT when needed. In selected experiments, cytoskeleton actin fiber distribution was evaluated by binding of 2 g/ml FITC-conjugated phalloidin (Sigma). All samples were counterstained by 1 g/ml propidium iodide or 0.5 g/ml Hoechst for 30 s, mounted with anti-fade mounting medium (Vector Laboratories, Burlingame, CA), and examined by UV light microscopy.
FACS Analysis
For FACS analysis, cells were detached with EDTA and stained for 1 h at 4°C with primary antibodies directed to human Fas or megalin or with an irrelevant control antibody. After extensive washing, cells In the presence of cisplatin (5 g/ml), a significant increase of apoptotic cells was detected (*P Ͻ 0.05 CIS versus vehicle). Addition of 10 ng/ml MSP resulted in a significant decrease of apoptosis either in serum-deprived (*P Ͻ 0.05 MSP versus vehicle alone) or in cisplatin-treated ( § P Ͻ 0.05 CIS ϩ MSP versus CIS) cells. Data are expressed as average number of apoptotic cells/ field. ANOVA with Newman-Keuls multicomparison test was performed. Magnifications: ϫ100 in A through H; ϫ600 in F inset.
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Western Blot Analysis
For Western blot analysis, cells were detached with EDTA and lysed with a 50-mM Tris-HCl lysis buffer containing 1% Triton X-100, 10 M/ml leupeptin, 10 M PMSF, and 100 U/ml aprotinin. After centrifugation of TEC lysates at 15000 ϫ g, protein contents of the supernatants were measured by the Bradford method: 30 g of protein per lane was subjected to SDS-PAGE (10%) and electroblotted onto nitrocellulose membrane filters. Blots were subsequently blocked with 5% nonfat milk in 20 mM Tris-HCl (pH 7.5), 500 mM NaCl, and 0.1% Tween. Membranes were incubated overnight at 4°C with antibodies directed to Akt, P-Akt, ERK, P-ERK, Bcl-xL (Santa Cruz Biotechnology), or Pax-2 at a concentration of 500 ng/ml. After extensive washing with 0.1% Tween, blots were stained for 1 h, RT with horseradish peroxidase-conjugated protein A (200 ng/ml; Amersham, Buckingamshire, UK), washed again with 0.1% Tween, developed with ECL detection reagents (Amersham), and exposed to X-Omat film (Eastman Kodak, Rochester, NY).
Evaluation of Transepithelial Electrical Resistance
Transepithelial electrical resistance was used as an indicator of cell polarity. Cells were plated in transwells on collagen-coated polycarbonate membranes (Corning Costar Corp., Cambridge, MA) and allowed to reach confluence before the addition of different stimuli. An epithelial volt-ohm meter (EVOM; World Precision Instruments, Sarasota, FL) was used to determine transepithelial electrical resistance values as described previously. 53 All measures were performed in triplicate and normalized for the area of the membrane.
TEC Adhesion to Extracellular Matrixes
Adhesion to extracellular matrices was evaluated on 24-well culture plates previously coated for 6 h with 20 g/ml human fibronectin, type IV collagen, or Matrigel (Becton Dickinson, Oxford, UK). Nonspecific adhesion was blocked by incubation for 2 h with 2% BSA diluted in 1ϫ PBS. TEC were exposed to different stimuli for 6 h at 37°C in conditions of slight agitation. 33 Thereafter, aliquots of stimulated cells were added to the wells and allowed to adhere for 2 h at 37°C. Supernatants were then removed, and attached cells were subjected to the XTT-based assay as reported previously.
Uptake of FITC-Conjugated Albumin
Protein uptake was studied after incubation of TEC with 50 mg/ml FITC-conjugated human albumin at 37°C for 2 h. After FITC-albumin challenge, TEC were extensively washed with ice-cold 1ϫ PBS and analyzed by FACS. 54 
Migration and Morphogenesis Assays
Migration was evaluated as the speed at which TEC migrated into a wound generated in a confluent monolayer to simulate a condition of mechanical stress. Cell motility was observed during a 12-h period under a Nikon Diaphot inverted microscope with a ϫ10 phase-contrast objective in an attached, hermetically sealed Plexiglas Nikon Np-2 incubator at 37°C. Migration was analyzed after recording on a JVC-ICCD video camera with digital saving of different images at 30-min intervals using the Micro-Image analysis system (Casti Imaging). Cellular migration was evaluated by marking the position of the nucleus of Ͼ30 cells per microscopic field for each experimental condition. 55 Speed average expressed in m/h was calculated as the ratio of straight-line distance between the starting and ending points of observation divided by the time of observation. In selected experiments, the PI3K inhibitor wortmannin (0.1 M), PD98059 (20 M), a specific inhibitor of Mek that activates ERK, or a blocking anti-MET antibody (R&D Systems) was used. Moreover, we evaluated scattered cell migration after seeding TEC on plates previously coated with 20 g/ml fibronectin, type IV collagen, or Matrigel. 56 Morphogenesis assay was performed on TEC cultured onto Matrigel for 72 h in the presence of various stimuli. Figure 12 . MSP maintained markers of tubular cell integrity in cisplatin-treated TEC-GFP after subcutaneous xenograft in SCID mice. Representative confocal microscopy images of TEC-GFP injected subcutaneously into Matrigel plugs in SCID mice in the presence of 5 g/ml cisplatin and 10 ng/ml MSP. TEC-GFP formed tubular-like structures characterized by staining for human class I HLA and by maintained expression of RON, of the endocytic receptor megalin, and of the tight junction protein ZO-1. In merge micrographs, nuclei were counterstained by 0.5 g/ml Hoechst. Six experiments were performed with similar results. Magnification, ϫ600.
RNA Interference
In selected experiments, TEC were seeded on six-well plates and RON siRNA, MET siRNA, or relative control siRNA (80 pM) was introduced according to the manufacturer's instructions (Santa Cruz Biotechnology). After 48 h, the effective suppression of specific mRNA and proteins was verified by RT-PCR and by immunofluorescence and Western blot analysis. Subsequently, the cells were used to evaluate proliferation, resistance to apoptosis, and migration.
Generation of Lentiviral Vectors and TEC Infection
Viral production was performed as described previously. 57, 58 Viral preparation titers were determined by p24 ELISA (Alliance, PerkinElmer, Wellesley, MA) and by GFP titer determination on 293T cells. Titers were typically 1E10 transduction units per ml in concentrated vector preparations. For gene marking, TEC were plated on 24-well plates in normal culture conditions and then transduced overnight with a lentivector carrying a CMV-GFP expression cassette at multiplicity of infection of approximately 20. Culture medium was replaced with fresh medium the next day. Transduction was confirmed by UV light microscopy and FACS analysis. The cell line generated was named TEC-GFP.
Subcutaneous Xenografts of TEC-GFP into Matrigel Plugs in SCID Mice
Subcutaneous xenotransplantation of TEC-GFP in Matrigel plugs was performed to evaluate the tubulogenic effect of MSP in vivo. Briefly, Matrigel deprived from growth factors (Becton Dickinson) was maintained at Ϫ20°C until use and thawed at 4°C overnight immediately before implantation. TEC-GFP (5 ϫ 10 3 cells) were resuspended in 250 l of fresh medium without FCS and mixed to 500 l of Matrigel on ice using cooled pipette tips in the presence of various stimuli. All samples were subcutaneously implanted into the posterior limbs of SCID mice. 59 After 1 wk, mice were killed and Matrigel plugs were retrieved for examination. Confocal microscopy analysis was performed to detect tubulogenesis and the expression of human class I-HLA, RON, megalin, and ZO-1 on TEC-GFP. In addition, TUNEL assay by using a peroxidase-conjugated antibody was performed to detect apoptotic cells into Matrigel plugs.
Statistical Analysis
All data of various experimental procedures are expressed as averages Ϯ 1 SD. Statistical analysis was performed by ANOVA with Newman-Keuls or Dunnet multicomparison test where appropriate.
